AP2XII9

AP2XII-9 (TgAP2XII-9) is a nuclear AP2-family transcription factor that operates as an S/M-phase master regulator of the Toxoplasma gondii tachyzoite cell cycle, coordinating daughter cell formation while suppressing developmental stage conversion (PMID:39207100, PMID:40106192). Its protein abundance oscillates through the cell cycle, peaking sharply during the S/M-subtranscriptome window (PMID:39207100, PMID:20865045), consistent with a role in delivering a transcriptional program at the point of division. Through its AP2 DNA-binding domain, which is required for function, it directly occupies several hundred gene promoters, activating genes for moving junction machinery (RON2, RON4, RON8), the daughter inner membrane complex, and de novo microneme formation, while repressing genes governing budding initiation (PMID:39207100, PMID:39774584). Conditional knockdown, replicated in type I RH and type II Pru strains, causes downregulation of rhoptry and rhoptry-neck proteins and of tachyzoite growth genes, producing defective daughter bud formation, disrupted apicoplast inheritance, impaired invasion and egress, and failure of intracellular proliferation (PMID:39207100, PMID:40106192). Depletion also derepresses bradyzoite-specific genes even without alkaline stress, establishing AP2XII-9 as an active repressor of bradyzoite differentiation (PMID:40106192). Epistasis with TgAP2III-2 shows AP2XII-9 holds the dominant role in daughter cell assembly (PMID:39774584).

1. 2010 Low

   Establishing whether AP2XII-9 is cell-cycle regulated was the first step in linking it to a specific replicative window; profiling showed its protein peaks sharply in the S/M phase, implicating it in division-associated transcription.

   Evidence Cell cycle transcriptome and protein expression timing profiling in tachyzoites

   PMID:20865045

   Open questions at the time

   • Expression profiling only; no functional characterization of AP2XII-9 specifically
   • No promoter targets or DNA-binding activity demonstrated
   • No phenotype from perturbation
2. 2024 High

   To determine what AP2XII-9 does mechanistically, genome-wide binding and conditional depletion were combined, showing it is a nuclear S/M-phase factor that directly targets moving junction and IMC promoters and is required for invasion, egress, budding, and apicoplast inheritance.

   Evidence CUT&Tag, conditional knockdown, invasion/egress assays, and transcriptomics

   PMID:39207100

   Open questions at the time

   • Single lab and strain background
   • Direct versus indirect effects on rhoptry protein levels not fully separated
   • Co-regulators or chromatin partners not identified
3. 2024 High

   Whether the AP2 domain drives function and how AP2XII-9 ranks among related factors was resolved by domain mutagenesis and epistasis, showing the AP2 DNA-binding domain is critical and that AP2XII-9 dominates daughter cell assembly over TgAP2III-2 by both activating microneme genes and repressing budding-initiation genes across ~300 promoters.

   Evidence CUT&Tag, transcriptomics, AP2 domain mutagenesis, and double-mutant epistasis

   PMID:39774584

   Open questions at the time

   • DNA sequence motif recognized by the AP2 domain not defined
   • Mechanism distinguishing activated versus repressed targets unresolved
   • Nature of the AP2XII-9/AP2III-2 functional relationship not mechanistically detailed
4. 2025 High

   Whether AP2XII-9's role extends to controlling developmental fate was addressed by conditional knockdown in two strains, showing depletion downregulates tachyzoite growth genes and upregulates bradyzoite-specific genes even without alkaline stress, establishing AP2XII-9 as an active repressor of stage conversion.

   Evidence Conditional knockdown in RH and Pru strains, transcriptomics, and immunofluorescence localization

   PMID:40106192

   Open questions at the time

   • Direct bradyzoite-gene promoter occupancy not shown as the repression mechanism
   • Whether repression is direct or a consequence of cell-cycle arrest unresolved
   • In vivo relevance to chronic infection not established

• The DNA motif recognized by the AP2XII-9 AP2 domain, its chromatin/co-regulator partners, and whether bradyzoite-gene repression is direct remain unresolved.
• No defined consensus binding motif
• No identified protein interaction partners or complexes
• Direct versus indirect basis of bradyzoite repression unknown